AEVEX Raises $320 Million in IPO Amid Surging Defense Sector Demand 
Elon Musk's Terafab Foundry Courts Top Chipmaking Giants for AI Self-Sufficiency Push 
SK Hynix Shares Hit Record High Amid AI Memory Demand Surge 
NiSource Signs Long-Term Energy Deals with Alphabet and Amazon to Power Indiana Data Centers 
CSN's Cement Unit Sale Could Exceed $2 Billion as Global Giants Circle 
CATL Stock Hits Record High After Q1 2025 Earnings Surge 
Uber Bets Big on Autonomous Vehicles with $10 Billion Commitment 
OpenAI's $20 Billion Cerebras Deal Signals Massive AI Infrastructure Push 
Federal Judge Dismisses DOJ Lawsuit Attempting to Block Hawaii's Climate Case Against Oil Giants 
Federal Agencies Secretly Test Anthropic's AI Despite Trump Administration Ban 
KKR's $820M Investment Fuels Samsung SDS AI Expansion, Sending Group Shares Soaring 
Iran War Drives Asia's Plastic Crisis — and a Green Packaging Boom 
Netflix Q2 Profit Warning Sends Shares Tumbling as Reed Hastings Exits 
Qantas Raises Fuel Cost Forecast Amid Middle East Oil Crisis 
DEEPX Partners with Hyundai to Power Next-Gen AI Robots Ahead of IPO 
Goldman Sachs FICC Revenue Falls 10% Amid Iran War Market Volatility 
TSMC Posts Record Q1 Profit Fueled by AI Chip Demand 
Los Angeles, April 08, 2016 -- Liposuction expert Dr. David Amron will be a key speaker at the Fat Disorders Research Society (FDRS) 2016 Conference in St. Louis, Missouri on April 8 through 10 at The Marriot St. Louis Airport hotel. With this year’s conference titled “Living with Lipedema and Dealing with Dercum’s Disease,” the Beverly Hills, California-based dermatologic surgeon, who is considered a pioneer in lipedema treatment, has been invited to speak on his unique circumferential approach to liposuction on the conference’s surgical panel.
“I’m very happy to once again attend the FDRS conference,” said Dr. Amron. “Despite the large number of individuals suffering with lipedema, it is still a disease that is both commonly misdiagnosed and mistreated. In fact, because of its high risk, many surgeons refuse to treat lipedema patients. At this conference, I plan to not only expand my own knowledge of the disease, but also to help educate attendees about my very real and successful treatment method.”
Currently, it is estimated that more than 17 million women nationwide struggle with lipedema, a fat storage condition affecting the limbs. The only known treatment option shown to work is pure tumescent liposuction, which Dr. Amron is an expert in. Using proprietary techniques, he has already helped hundreds of patients with the disease make the return to full mobility.
Annually, the FDRS conference brings together top physicians and researchers in the industry to discuss, educate, and network on topics surrounding adipose tissue disorders and treatment options. This year, in addition to Dr. Amron’s discussion on treating lipedema with liposuction, attendees can also look forward to lectures on properly diagnosing the disease, as well as information on proper nutrition, exercise, and therapies for lipedema.
To find out more about the FDRS 2016 conference, please visit: http://www.fatdisorders.org/. For more information or to schedule an appointment with Dr. Amron, please visit: www.amronmd.com and www.theroxburyinstitute.com, or call (424) 394-1610.
###
About David Amron, M.D.
Dr. David Amron is a board certified dermatologic surgeon specializing in lipedema treatment, liposuction, and body contouring. He is medical director of the Roxbury Institute in Beverly Hills, California and has a worldwide reputation for excellence in successfully approaching complicated liposuction cases, including lipedema treatments and revision liposuction surgeries. He also specializes in nonsurgical facial rejuvenation and is internationally renowned for his artistry and unique approach to lipo-sculpture surgery.
Matt Rindone, Media Representative [email protected] 323.937.1951
